RP

Ruhrpharm is an independent pharmaceutical company focused on the therapeutic area of urology. The company aims to improve quality of life by helping prevent, alleviate and treat disease, while supporting the reliable supply of high-quality pharmaceuticals, medical technology and related services for urological care. It serves doctors, pharmacies and patients, positioning itself as a competent and dependable partner.

Ruhrpharm’s offerings include pharmaceutical products and food supplements. Its product range features Aurufluxx, Sabalvit, Sabalvit Uno, Androfluxx, Cellfluxx, Cranfluxx, Curbifluxx, Diufluxx, Mannose, Terafluxx and Virivital. The company also identifies business development, international activities and memberships among its areas of work.

Ruhrpharm describes its approach as sustainable and grounded in social and ethical responsibility. It recognizes the interests of its stakeholders and responds to the healthcare needs associated with a growing and aging population. Through its focus on urology and its support for medical professionals and patients, Ruhrpharm works to contribute to care for people affected by urological diseases.